Search PubMedSearch

PubMed · 8858188

Chorea.

Abstract

The Huntington's disease mutation and its protein product are widely expressed in the brain, although the link to presumed excitotoxic damage is unknown. The availability of the genetic test increased the study of preclinical changes in the disease and the identification of more rare choreic illnesses. Other types of transient or permanent basal ganglia dysfunction might cause chorea.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K M Shannon. 1996. Chorea.. https://doi.org/10.1097/00019052-199608000-00010

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

The regulation of forebrain dopamine transmission: relevance to the pathophysiology and psychopathology of schizophrenia.

Since the discovery that the therapeutic efficacy of antipsychotic drugs was significantly correlated to their ability to block dopamine D2 receptors, abnormal dopamine transmission in the forebrain has been postulated to underlie psychosis in schizophrenia. In the past 15 years, an impressive amount of clinical and basic research aimed at the study of schizophrenia has indicated that prefrontal and temporal cortical abnormalities may be more important in the etiology of many of the symptoms of schizophrenia, including psychosis. However, the cortical systems that appear to have structural and/or metabolic abnormalities in schizophrenia patients potently regulate forebrain dopamine transmission through a number of mechanisms. In turn, dopamine modulates excitatory transmission mediated by frontal and temporal cortical projections to the basal ganglia and other regions. The present review summarizes the multiple interactions between forebrain DA systems and frontal and temporal corticostriatal transmission. It then examines the role of these interactions in normal behaviors and the psychopathology of schizophrenia.

Basal Ganglia

Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease.

BACKGROUND: Traditional imaging methods, including computed tomography, routine magnetic resonance imaging (MRI), and magnetic resonance spectroscopy, have not been particularly useful in the diagnosis of Creutzfeldt-Jakob disease (CJD). Although abnormalities can be seen using these methods, the findings are evident only late in the disease or lack specificity or sensitivity. OBJECTIVE: To describe abnormalities on diffusion-weighted MRIs in 4 patients with proven CJD. METHODS: Diffusion-weighted MRIs were obtained on 4 patients with CJD as part of a routine MRI brain examination. RESULTS: In all 4 patients, diffusion-weighted MRIs of the brain demonstrated bilateral hyperintensity in the basal ganglia. In 1 patient, the most conspicuous abnormality seen in diffusion-weighted images was in the thalamus. Two patients also demonstrated hyperintensity in the cerebral cortex on diffusion-weighted images. Only 2 of 4 patients demonstrated clear abnormalities on routine (non-diffusion-weighted) MRIs. Diffusion abnormalities were visible in 1 patient within 1 month of symptom onset. The findings were most conspicuous and extensive in the patient with the longest duration of symptoms (7 months). CONCLUSIONS: Diffusion-weighted MRI might provide a noninvasive method of identifying patients with CJD. However, further investigations must be performed to determine the specificity of these findings for CJD.

Basal Ganglia